MLYS
Mineralys Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$26.19
-0.80 ▼ -2.96%
🌙 3월 13일 7:07 PM ET (한국 3/14 08:07)
$26.28
+0.09 ▲ +0.34%
| Index | RUT | P/E | - | EPS (ttm) | -2.38 | Insider Own | 25.47% | Shs Outstand | 0.08B | Perf Week | -1.5% |
| Market Cap | 2.16B | Forward P/E | - | EPS next Y | 16.33% | Insider Trans | -8.03% | Shs Float | 0.06B | Perf Month | -12.06% |
| Enterprise Value | 1.50B | PEG | - | EPS next Q | -0.49 | Inst Own | 91.94% | Short Float | 16.29% | Perf Quarter | -27.65% |
| Income | -0.15B | P/S | - | EPS this Y | 3.49% | Inst Trans | 12.1% | Short Ratio | 7.61 | Perf Half Y | -29.52% |
| Sales | 0.00B | P/B | 3.3 | EPS next 5Y | 26.17% | ROA | -35.65% | Short Interest | 9.61M | Perf YTD | -27.83% |
| Book/sh | 7.93 | P/C | 3.29 | EPS past 3/5Y | -46.34% -101.68% | ROE | -36.91% | 52W High | -45.04% ($47.65) | Perf Year | 94% |
| Cash/sh | 7.97 | P/FCF | - | Sales past 3/5Y | - | ROIC | -23.91% | 52W Low | 150.86% ($10.44) | Perf 3Y | 61.67% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 34.72% | Gross Margin | - | Volatility(W/M) | 11.5% 6.95% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 2.04 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 43.76 | EPS Q/Q | 59.15% | Profit Margin | - | RSI (14) | 36.3 | Recom | 1.25 |
| Dividend Gr. 3/5Y | - | Current Ratio | 43.76 | Sales Q/Q | - | SMA20 | -6.89% ($28.13) | Beta | 0.67 | Target Price | $49.38 |
| Payout | - | Debt/Eq | 0 | Earnings | 3000000 | SMA50 | -14.65% ($30.69) | Rel Volume | 1.1 | Prev Close | $26.99 |
| Employees | 76 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 22.53% - | SMA200 | -9.53% ($28.95) | Avg Volume(3M) | 1.26M | Price | $26.19 |
| IPO | 2023/2/10 | Option/Short | Yes/Yes | Trades | 14832 | Volume | 1,393,543 | Change | -2.96% |
뉴스 로딩 중...